Browse every story filed under this topic, curated from trusted publishers around the world.
A day after the DOJ said it would ease restrictions on medical marijuana, the FDA moves to fast-track some experimental psychedelic drugs for review. They're looking at three drugs for treatment-resistant depression, major depressive disorder, and …
Read full story →
The Food and Drug Administration (FDA) on Friday granted fast-track review to three companies studying psychedelic therapies to treat depression …
The FDA is issuing national priority vouchers to three companies studying psychedelic drugs to treat serious mental illness. The vouchers …
The Food and Drug Administration on Friday granted a quick review of three experimental psychedelic drugs meant to treat major …
The federal government launched a behavioral health research initiative, with $50 million allocated to match state investments in psychedelic research, …
A plant-based psychoactive compound, ibogaine, is making headlines. President Donald Trump signed an executive order to accelerate research, regulatory review …
President Trump has signed an executive order aimed at accelerating research and approval of psychedelics for treating mental health conditions, …
Out of Town Blog 10 Ways Solo Parents Can Support a Child Struggling with Mental Health As a solo parent, …
You've seen all articles for #depression.
Check back
soon
for new stories.